Comparison of Two NN1250 Formulations in Subjects With Type 1 Diabetes

NCT01076634 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 1

Interventions

DRUG: insulin degludec
DRUG: insulin degludec

Sponsor

Novo Nordisk A/S